MED19 anticorps
Aperçu rapide pour MED19 anticorps (ABIN7116124)
Antigène
Voir toutes MED19 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Fonction
- MED19 antibody
-
Purification
- Immunogen affinity purified
-
Pureté
- ≥95 % as determined by SDS-PAGE
-
Immunogène
- mediator complex subunit 19
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB: 1:500-1:2000, IHC: 1:20-1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freeze / thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C for 12 months
-
Date de péremption
- 12 months
-
-
- MED19 (Mediator Complex Subunit 19 (MED19))
-
Autre désignation
- MED19
-
Sujet
-
Synonyms: Mediator of RNA polymerase II transcription subunit 19|Lung cancer metastasis-related protein 1|Mediator complex subunit 19|MED19|LCMR1
Background: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors.
-
Poids moléculaire
- 31 kDa
-
ID gène
- 219541
-
UniProt
- A0JLT2
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha
Antigène
-